Ahmed Tawakol1, Amorina Ishai2, Richard Ap Takx2, Amparo L Figueroa2, Abdelrahman Ali2, Yannick Kaiser2, Quynh A Truong3, Chloe Je Solomon4, Claudia Calcagno4, Venkatesh Mani4, Cheuk Y Tang4, Willem Jm Mulder4, James W Murrough5, Udo Hoffmann2, Matthias Nahrendorf6, Lisa M Shin7, Zahi A Fayad4, Roger K Pitman8. 1. Cardiology Division, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Cardiac MR PET CT Program, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. Electronic address: atawakol@mgh.harvard.edu. 2. Cardiac MR PET CT Program, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. 3. Radiology Department, Weil Cornell Medical College, New York, NY, USA. 4. Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 5. Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 6. Center for Systems Biology, Massachusetts General Hospital, Boston, MA, USA. 7. Department of Psychology, Tufts University, Medford, MA, USA. 8. Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Abstract
BACKGROUND: Emotional stress is associated with increased risk of cardiovascular disease. We imaged the amygdala, a brain region involved in stress, to determine whether its resting metabolic activity predicts risk of subsequent cardiovascular events. METHODS: Individuals aged 30 years or older without known cardiovascular disease or active cancer disorders, who underwent 18F-fluorodexoyglucose PET/CT at Massachusetts General Hospital (Boston, MA, USA) between Jan 1, 2005, and Dec 31, 2008, were studied longitudinally. Amygdalar activity, bone-marrow activity, and arterial inflammation were assessed with validated methods. In a separate cross-sectional study we analysed the relation between perceived stress, amygdalar activity, arterial inflammation, and C-reactive protein. Image analyses and cardiovascular disease event adjudication were done by mutually blinded researchers. Relations between amygdalar activity and cardiovascular disease events were assessed with Cox models, log-rank tests, and mediation (path) analyses. FINDINGS: 293 patients (median age 55 years [IQR 45·0-65·5]) were included in the longitudinal study, 22 of whom had a cardiovascular disease event during median follow-up of 3·7 years (IQR 2·7-4·8). Amygdalar activity was associated with increased bone-marrow activity (r=0·47; p<0·0001), arterial inflammation (r=0·49; p<0·0001), and risk of cardiovascular disease events (standardised hazard ratio 1·59, 95% CI 1·27-1·98; p<0·0001), a finding that remained significant after multivariate adjustments. The association between amygdalar activity and cardiovascular disease events seemed to be mediated by increased bone-marrow activity and arterial inflammation in series. In the separate cross-sectional study of patients who underwent psychometric analysis (n=13), amygdalar activity was significantly associated with arterial inflammation (r=0·70; p=0·0083). Perceived stress was associated with amygdalar activity (r=0·56; p=0·0485), arterial inflammation (r=0·59; p=0·0345), and C-reactive protein (r=0·83; p=0·0210). INTERPRETATION: In this first study to link regional brain activity to subsequent cardiovascular disease, amygdalar activity independently and robustly predicted cardiovascular disease events. Amygdalar activity is involved partly via a path that includes increased bone-marrow activity and arterial inflammation. These findings provide novel insights into the mechanism through which emotional stressors can lead to cardiovascular disease in human beings. FUNDING: None.
BACKGROUND: Emotional stress is associated with increased risk of cardiovascular disease. We imaged the amygdala, a brain region involved in stress, to determine whether its resting metabolic activity predicts risk of subsequent cardiovascular events. METHODS: Individuals aged 30 years or older without known cardiovascular disease or active cancer disorders, who underwent 18F-fluorodexoyglucose PET/CT at Massachusetts General Hospital (Boston, MA, USA) between Jan 1, 2005, and Dec 31, 2008, were studied longitudinally. Amygdalar activity, bone-marrow activity, and arterial inflammation were assessed with validated methods. In a separate cross-sectional study we analysed the relation between perceived stress, amygdalar activity, arterial inflammation, and C-reactive protein. Image analyses and cardiovascular disease event adjudication were done by mutually blinded researchers. Relations between amygdalar activity and cardiovascular disease events were assessed with Cox models, log-rank tests, and mediation (path) analyses. FINDINGS: 293 patients (median age 55 years [IQR 45·0-65·5]) were included in the longitudinal study, 22 of whom had a cardiovascular disease event during median follow-up of 3·7 years (IQR 2·7-4·8). Amygdalar activity was associated with increased bone-marrow activity (r=0·47; p<0·0001), arterial inflammation (r=0·49; p<0·0001), and risk of cardiovascular disease events (standardised hazard ratio 1·59, 95% CI 1·27-1·98; p<0·0001), a finding that remained significant after multivariate adjustments. The association between amygdalar activity and cardiovascular disease events seemed to be mediated by increased bone-marrow activity and arterial inflammation in series. In the separate cross-sectional study of patients who underwent psychometric analysis (n=13), amygdalar activity was significantly associated with arterial inflammation (r=0·70; p=0·0083). Perceived stress was associated with amygdalar activity (r=0·56; p=0·0485), arterial inflammation (r=0·59; p=0·0345), and C-reactive protein (r=0·83; p=0·0210). INTERPRETATION: In this first study to link regional brain activity to subsequent cardiovascular disease, amygdalar activity independently and robustly predicted cardiovascular disease events. Amygdalar activity is involved partly via a path that includes increased bone-marrow activity and arterial inflammation. These findings provide novel insights into the mechanism through which emotional stressors can lead to cardiovascular disease in human beings. FUNDING: None.
Authors: Michael T Osborne; Azar Radfar; Malek Z O Hassan; Shady Abohashem; Blake Oberfeld; Tomas Patrich; Brian Tung; Ying Wang; Amorina Ishai; James A Scott; Lisa M Shin; Zahi A Fayad; Karestan C Koenen; Sanjay Rajagopalan; Roger K Pitman; Ahmed Tawakol Journal: Eur Heart J Date: 2020-02-01 Impact factor: 29.983
Authors: Kasra Moazzami; Matthew T Wittbrodt; Bruno B Lima; Jonathon A Nye; Puja K Mehta; Brad D Pearce; Zakaria Almuwaqqat; Muhammad Hammadah; Oleksiy Levantsevych; Yan V Sun; Paolo Raggi; Ernest V Garcia; Margarethe Goetz; Arshed A Quyyumi; J Douglas Bremner; Viola Vaccarino; Amit J Shah Journal: Circulation Date: 2020-06-11 Impact factor: 29.690
Authors: Jennifer A Sumner; Laura D Kubzansky; Andrea L Roberts; Qixuan Chen; Eric B Rimm; Karestan C Koenen Journal: Psychol Med Date: 2019-01-04 Impact factor: 7.723
Authors: Robin Nusslock; Gene H Brody; Casey C Armstrong; Ann L Carroll; Lawrence H Sweet; Tianyi Yu; Allen W Barton; Emily S Hallowell; Edith Chen; James P Higgins; Todd B Parrish; Lei Wang; Gregory E Miller Journal: Biol Psychiatry Date: 2019-05-01 Impact factor: 13.382
Authors: Michael T Osborne; Amorina Ishai; Basma Hammad; Brian Tung; Ying Wang; Amos Baruch; Zahi A Fayad; Jon T Giles; Janet Lo; Lisa M Shin; Steven K Grinspoon; Karestan C Koenen; Roger K Pitman; Ahmed Tawakol Journal: Psychoneuroendocrinology Date: 2018-09-22 Impact factor: 4.905
Authors: Daniel B McKim; Wenyuan Yin; Yufen Wang; Steve W Cole; Jonathan P Godbout; John F Sheridan Journal: Cell Rep Date: 2018-11-27 Impact factor: 9.423